NIV-142 20 mg Pill - yellow & white capsule-shape, 18mm
Pill with imprint NIV-142 20 mg is Yellow & White, Capsule-shape and has been identified as Temozolomide 20 mg. It is supplied by Nivagen Pharmaceuticals, Inc.
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NIV-142 20 mg
Temozolomide
- Imprint
- NIV-142 20 mg
- Strength
- 20 mg
- Color
- Yellow & White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Nivagen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 75834-0142
- Inactive Ingredients
-
gelatin,
titanium dioxide,
ferric oxide yellow,
shellac,
butyl alcohol,
isopropyl alcohol,
propylene glycol,
ammonia,
potassium hydroxide,
ferrosoferric oxide,
water,
alcohol
Note: Inactive ingredients may vary.
More about temozolomide
- Check interactions
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Drug Information
- Temozolomide (Advanced Reading)
- Temozolomide Intravenous (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
